Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1902)
All Articles published online
|
Jan 28, 2007 (publication date) through Sep 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu W, Mao SY, Zhu WY. Impact of tiny miRNAs on cancers. World J Gastroenterol 2007; 13(4): 497-502 [PMID: 17278213 DOI: 10.3748/wjg.v13.i4.497] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/497.htm |
| Number | Citing Articles |
| 1 |
Yasan Sadeghian, Zahra Kamyabi-Moghaddam, Seyed Mohamad Hossein Tabatabaei Nodushan, Samaneh Khoshbakht, Behnam Pedram, Emad Yahaghi, Aram Mokarizadeh, Mahdi Mohebbi. RETRACTED ARTICLE: Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma. Tumor Biology 2016; 37(12): 16379 doi: 10.1007/s13277-015-3799-y
|
| 2 |
Ge Yu, Jian‐qiang Tang, Mao‐lin Tian, Hui Li, Xin Wang, Tao Wu, Jing Zhu, Shan‐jun Huang, Yuan‐lian Wan. Prognostic values of the miR‐17‐92 cluster and its paralogs in colon cancer. Journal of Surgical Oncology 2012; 106(3): 232 doi: 10.1002/jso.22138
|
| 3 |
Ahmad Mahdian-shakib, Ruhollah Dorostkar, Mahdi Tat, Mohammad Sadegh Hashemzadeh, Navid Saidi. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer. Biomedicine & Pharmacotherapy 2016; 84: 592 doi: 10.1016/j.biopha.2016.09.087
|
| 4 |
Sercan Kenanoglu, Hilal Akalin, Dicle Aslan, Mevlude Inanc, Figen Ozturk, Munis Dundar. Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer. Gene Reports 2024; 37: 102020 doi: 10.1016/j.genrep.2024.102020
|
| 5 |
Tuan Meng Lee, Leonard Lipovich. Structural differences of orthologous genes: Insights from human–primate comparisons. Genomics 2008; 92(3): 134 doi: 10.1016/j.ygeno.2008.05.006
|
| 6 |
Erin Connolly, Margherita Melegari, Pablo Landgraf, Tatyana Tchaikovskaya, Bud C. Tennant, Betty L. Slagle, Leslie E. Rogler, Mihaela Zavolan, Thomas Tuschl, Charles E. Rogler. Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype. The American Journal of Pathology 2008; 173(3): 856 doi: 10.2353/ajpath.2008.080096
|
| 7 |
Joel Pekow, Katherine Meckel, Urszula Dougherty, Yong Huang, Xindi Chen, Anas Almoghrabi, Reba Mustafi, Fatma Ayaloglu-Butun, Zifeng Deng, Haider I. Haider, John Hart, David T. Rubin, John H. Kwon, Marc Bissonnette. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clinical Cancer Research 2017; 23(17): 5281 doi: 10.1158/1078-0432.CCR-17-0171
|
| 8 |
Ling Xu, Wei-Qi Dai, Xuan-Fu Xu, Fan Wang, Lei He, Chuan-Yong Guo. Effects of Multiple-target Anti-microRNA Antisense Oligodeoxyribonucleotides on Proliferation and Migration of Gastric Cancer Cells. Asian Pacific Journal of Cancer Prevention 2012; 13(7): 3203 doi: 10.7314/APJCP.2012.13.7.3203
|
| 9 |
Masoomeh Dadpay, Mojtaba Zarea, Rahman Ghaffarzadegan Rabati, Bijan Rezakhaniha, Babak Barari, Vahid Behnod, Katayoun Ziari. RETRACTED ARTICLE: Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis. Tumor Biology 2016; 37(12): 16383 doi: 10.1007/s13277-015-3905-1
|
| 10 |
Junlong Zhang, Xinhua Xiao, Linong Ji. Epigenetic disorder plays a fundamental role in the etiology of type 2 diabetes. Wuhan University Journal of Natural Sciences 2013; 18(1): 9 doi: 10.1007/s11859-013-0886-z
|
| 11 |
Joel Pekow, Katherine Meckel, Urszula Dougherty, Fatma Butun, Reba Mustafi, John Lim, Charis Crofton, Xindi Chen, Loren Joseph, Marc Bissonnette. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(3): G179 doi: 10.1152/ajpgi.00208.2014
|
| 12 |
Zhaoji Luan, Baoliang Liu, Lina Shi. Angiotensin II‐induced micro RNA‐21 culprit for non‐small‐cell lung adenocarcinoma. Drug Development Research 2019; 80(8): 1031 doi: 10.1002/ddr.21597
|
| 13 |
Yukiharu Hiyoshi, Aaron J. Schetter, Hirokazu Okayama, Kentaro Inamura, Katsuhiro Anami, Giang H. Nguyen, Izumi Horikawa, Jason E. Hawkes, Elise D. Bowman, Suet Yi Leung, Curtis C. Harris, Hong Wang. Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer. PLOS ONE 2015; 10(4): e0124899 doi: 10.1371/journal.pone.0124899
|
| 14 |
Ajaz A. Bhat, Salma N. Younes, Syed Shadab Raza, Lubna Zarif, Sabah Nisar, Ikhlak Ahmed, Rashid Mir, Sachin Kumar, Surender K. Sharawat, Sheema Hashem, Imadeldin Elfaki, Michal Kulinski, Shilpa Kuttikrishnan, Kirti S. Prabhu, Abdul Q. Khan, Santosh K. Yadav, Wael El-Rifai, Mohammad A. Zargar, Hatem Zayed, Mohammad Haris, Shahab Uddin. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01175-9
|
| 15 |
Zhong-xue Su, Juan Zhao, Zhong-hou Rong, Wen-mao Geng, Ya-guang Wu, Cheng-kun Qin. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-47
|
| 16 |
Joel R. Pekow, Urszula Dougherty, Reba Mustafi, Hongyan Zhu, Masha Kocherginsky, David T. Rubin, Stephen B. Hanauer, John Hart, Eugene B. Chang, Alessandro Fichera, Loren J. Joseph, Marc Bissonnette. miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes. Inflammatory Bowel Diseases 2012; 18(1): 94 doi: 10.1002/ibd.21742
|
| 17 |
Tai-Yue Kuo, Edward Hsi, I-Ping Yang, Pei-Chien Tsai, Jaw-Yuan Wang, Suh-Hang Hank Juo, Steve Horvath. Computational Analysis of mRNA Expression Profiles Identifies MicroRNA-29a/c as Predictor of Colorectal Cancer Early Recurrence. PLoS ONE 2012; 7(2): e31587 doi: 10.1371/journal.pone.0031587
|
| 18 |
Mariana Ioniţă, George Mihail Vlăsceanu, Aiza Andreea Watzlawek, Stefan Ioan Voicu, Jorge S. Burns, Horia Iovu. Graphene and functionalized graphene: Extraordinary prospects for nanobiocomposite materials. Composites Part B: Engineering 2017; 121: 34 doi: 10.1016/j.compositesb.2017.03.031
|
| 19 |
Simon D. Brown, Eftychia Klimi, Wilfried A. M. Bakker, Abdelaziz Beqqali, Andrew H. Baker. Non‐coding RNAs to treat vascular smooth muscle cell dysfunction. British Journal of Pharmacology 2024; doi: 10.1111/bph.16409
|
| 20 |
Subasa Chandra Bishwal, Rituraj Niranjan. MicroRNA in Human Infectious Diseases. 2024; : 123 doi: 10.1016/B978-0-323-99661-7.00010-2
|
| 21 |
Lumin Wang, Jiayi Yao, Hongfei Sun, Kang He, Dongdong Tong, Tusheng Song, Chen Huang. MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A. Oncology Letters 2017; 13(1): 329 doi: 10.3892/ol.2016.5423
|
| 22 |
Jichuan Xu, Jian Xu, Xinyuan Liu, Jianxin Jiang. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01061-x
|
| 23 |
Lumin Wang, Jiayi Yao, Xin Shi, Lili Hu, Zongfang Li, Tusheng Song, Chen Huang. RETRACTED ARTICLE: MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-448
|
| 24 |
Jasdeep Kaur Dhanoa, Ramneek Verma, R. S. Sethi, Jaspreet Singh Arora, C. S. Mukhopadhyay. Biogenesis and biological implications of isomiRs in mammals- a review. ExRNA 2019; 1(1) doi: 10.1186/s41544-018-0003-8
|
| 25 |
Alexandros Ο. Konstantinidis, Dimitra Pardali, Katerina K. Adamama-Moraitou, Maria Gazouli, Chrysostomos I. Dovas, Evangelia Legaki, Georgia D. Brellou, Ioannis Savvas, Albert E. Jergens, Timoleon S. Rallis, Karin Allenspach. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Veterinary Research 2020; 16(1) doi: 10.1186/s12917-020-02287-6
|
| 26 |
Lin Liu, Lin Chen, Yingxin Xu, Rong Li, Xiaohui Du. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochemical and Biophysical Research Communications 2010; 400(2): 236 doi: 10.1016/j.bbrc.2010.08.046
|
| 27 |
PINGYU WANG, SHUYANG XIE, AIDONG CUI, YANXIANG ZHANG, BAOFA JIANG. miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects. Experimental and Therapeutic Medicine 2012; 3(2): 324 doi: 10.3892/etm.2011.399
|
| 28 |
T. V. Shirina, M. T. Bobrovskaya, E. A. Kozlov. MicroRNA: from fundamental research to their application. Biopolymers and Cell 2007; 23(6): 467 doi: 10.7124/bc.000781
|
| 29 |
Yoshinao Ruike, Atsuhiko Ichimura, Soken Tsuchiya, Kazuharu Shimizu, Ryo Kunimoto, Yasushi Okuno, Gozoh Tsujimoto. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. Journal of Human Genetics 2008; 53(6): 515 doi: 10.1007/s10038-008-0279-x
|
| 30 |
Adewale Oluwaseun Fadaka, Ashley Pretorius, Ashwil Klein. Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach. International Journal of Molecular Sciences 2019; 20(20): 5190 doi: 10.3390/ijms20205190
|
| 31 |
Joel R. Pekow, John H. Kwon. MicroRNAs in inflammatory bowel disease. Inflammatory Bowel Diseases 2012; 18(1): 187 doi: 10.1002/ibd.21691
|
| 32 |
Simona Ruxandra Volovat, Constantin Volovat, Irina Hordila, Dorin-Alexandru Hordila, Ciprian Camil Mirestean, Oana Tatiana Miron, Cristian Lungulescu, Dragos Viorel Scripcariu, Cati Raluca Stolniceanu, Assia Adrianova Konsoulova-Kirova, Cristina Grigorescu, Cipriana Stefanescu, Cristian Constantin Volovat, Iolanda Augustin. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.526850
|
| 33 |
Shengzhuo Liu, Shijian Feng, Deyi Luo. Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome. International Urogynecology Journal 2019; 30(9): 1487 doi: 10.1007/s00192-018-3817-x
|
| 34 |
Xia Wu, Cui Kong, Yilei Wu. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis. Bioengineered 2021; 12(1): 9046 doi: 10.1080/21655979.2021.1993715
|
| 35 |
YANG YANG, SU'E CHANG, ZHENGHAO ZHAO, NI HOU, KANG HE, XIAOFEI WANG, LING GAO, LUMIN WANG, DONGHUI CAI, BO GUO, DONGDONG TONG, TUSHENG SONG, CHEN HUANG. MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3. Oncology Letters 2015; 10(6): 3779 doi: 10.3892/ol.2015.3745
|
| 36 |
Cliff I. Oduor, Yasin Kaymaz, Kiprotich Chelimo, Juliana A. Otieno, John Michael Ong’echa, Ann M. Moormann, Jeffrey A. Bailey. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3711-9
|
| 37 |
Ernest Osei, Stephanie Swanson, Ruth Francis. Review of novel liquid-based biomarkers for prostate cancer: towards personalised and targeted medicine. Journal of Radiotherapy in Practice 2023; 22 doi: 10.1017/S1460396921000248
|
| 38 |
Srilekha Avvari, DKV Prasad, Imran Ali Khan. Role of MicroRNAs in Cancers. 2022; : 37 doi: 10.1007/978-981-16-9186-7_3
|
| 39 |
Smriti Gupta, Savita Verma, Shrikant Mantri, Nancy E. Berman, Rajat Sandhir. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders. Drug Development Research 2015; 76(7): 397 doi: 10.1002/ddr.21277
|
| 40 |
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz-Tretyn, Cezary Cybulski, Andrzej Tretyn. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. International Journal of Molecular Sciences 2023; 24(8): 7235 doi: 10.3390/ijms24087235
|
| 41 |
Liang Huang, Fei-Yan Deng, Shu-Feng Lei. Global correlation analysis for miRNA and protein expression profiles in human peripheral blood mononuclear cells. Molecular Biology Reports 2020; 47(7): 5295 doi: 10.1007/s11033-020-05608-y
|
| 42 |
Peyman Karimi Goudarzi, Afshin Taheriazam, Saeid Asghari, Mohammad Jamshidi, Mohammadreza Shakeri, Emad Yahaghi, Alireza Mirghasemi. RETRACTED ARTICLE: Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma. Tumor Biology 2016; 37(5): 5775 doi: 10.1007/s13277-015-4090-y
|
| 43 |
Tariq Alzahem, Waleed Alsarhani, Abdullah Albahlal, Leen Abu Safieh, Saad Aldahmash. Retinoblastoma - Past, Present and Future. 2019; doi: 10.5772/intechopen.89035
|
| 44 |
Qinggong Yuan, Gang Cao, Junhui Li, Yan Zhang, Wenbin Yang. MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling. Gene 2017; 628: 48 doi: 10.1016/j.gene.2017.07.031
|
| 45 |
Lalita A. Shevde, Brandon J. Metge, Aparna Mitra, Yaguang Xi, Jingfang Ju, Judy A. King, Rajeev S. Samant. Spheroid‐forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa‐miR‐299–5p regulated de novo expression of osteopontin. Journal of Cellular and Molecular Medicine 2010; 14(6b): 1693 doi: 10.1111/j.1582-4934.2009.00821.x
|
| 46 |
Yike Fu, Tong Chen, Gang Wang, Tongxu Gu, Congkun Xie, Jie Huang, Xiang Li, Serena Best, Gaorong Han. Production of a fluorescence resonance energy transfer (FRET) biosensor membrane for microRNA detection. Journal of Materials Chemistry B 2017; 5(34): 7133 doi: 10.1039/C7TB01399J
|